Pearls and Pitfalls in Nonmalignant Radiation Therapy: Challenging Case Presentations

Through a series of complex clinical scenarios, this activity examines decision-making strategies, technical considerations, and outcome optimization in nonmalignant condition management. Expert faculty present challenging cases highlighting best practices, common complications, and lessons learned from difficult clinical situations.

Target Audience

This activity is designed to meet the interests of radiation oncologists, physicists, radiation dosimetrists, radiation therapists and residents. 

Learning Objectives

Upon completion of this activity, participants should be able to do the following: 

  • Identify key clinical considerations in selecting patients for radiation therapy in nonmalignant conditions such as degenerative, inflammatory and functional disorders.
  • Evaluate complex, real-world cases to recognize common pitfalls and optimize treatment outcomes through tailored technique selection.
  • Discuss dose, fractionation and field design strategies that minimize complications while maintaining efficacy.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
09/15/2025
Course expires: 
09/14/2027
Cost:
$0.00
Part of: 
Radiation Therapy for Nonmalignant Conditions: Challenges and Updates (onDemand)
Rating: 
0
  • M. Heinrich Seegenschmiedt, MD, PhD, is employed by ergea MVZ Radiation Therapy Aalen. Dr. Seegenschmiedt receives honoraria as an Advisory Board member, consultant and education/meeting faculty from Varian Medical Systems; honoraria and travel expenses as a consultant and education/meeting faculty from RT-ABC Ltd. Dr. Seegenschmiedt is a Board Member of the International Dupuytren Society and serves as Clinical Chair of the International Organisation of Radiotherapy for Benign Conditions (IORBC). 
  • Richard Shaffer, MBBS, MD, is employed by RT-ABC Ltd. and Theralife Clinics. Dr. Shaffer receives compensation/payment as a consultant from Dermacure RT LLC and Xstrahl Ltd. Dr. Shaffer has ownership equity in RT-ABC Ltd., Xstrahl Ltd., and Theralife Clinics Ltd. Dr. Shaffer serves as President of the International Organisation of Radiotherapy for Benign Conditions (IORBC). 
  • Nagendra (Bobby) Koneru, MD, FASTRO, is employed by Loyola University Chicago Stritch School of Medicine. Dr. Koneru is Co-founder and Chief Medical Officer of Joint Glow. Dr. Koneru is a consultant with RadianceRT and CQ Medical. Dr. Koneru serves on the Advisory Board of Varian and Novartis. Dr. Koneru is a shareholder of RT-ABC Ltd.  

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

Available Credit

  • 1.00 Certificate of Attendance

This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.